An early diagnosis of illnesses such as cancer and heart disease can mean the difference between life and death. For decades, the primary source of these diagnoses were the physicians in the right fields. However, a new artificial intelligence being developed might be better than doctors when it comes to detecting diseases earlier and with more accuracy.
Developed by John Radcliffe Hospital researchers, the AI called Utromics can reportedly diagnose heart disease much faster than even specialists in the field are able to, the BBC reports. This new technology will apparently be rolled out to NHS hospitals soon, which could end up saving billions in medical fees thanks to early detection.
As the publication notes, even the best cardiologists or oncologists can miss certain signs of diseases, leading to one in five cases being misdiagnosed. With the AI, however, the computer is able to detect signs that humans would likely miss.
Cardiologists in the UK seems to be open to the idea of getting the help of an AI in diagnosing diseases, as well. Of course, there will be an oversight when using the machine and the doctors themselves will be looking at the data to confirm that there is actually cause for concern.
There’s also the startup called Optellum, which is developing an AI intended to detect early signs of lung cancer, Futurism reports. Based on trial results, it would seem that this particular machine can save up to 4,000 lung cancer patients a year more than human doctors.
The most obvious benefit of the emergence of AI diagnostic tools is the number of lives that will be saved, as a result. However, there is also the matter of financial savings to consider. On top of the medical bills that the patients and insurance companies need to pay, there is also the care and government coverage that would be incurred.


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Instagram Outage Disrupts Thousands of U.S. Users 



